Educational media for Latinx patients undergoing radiation therapy for breast or prostate cancer
Audiovisual Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment (ADELANTE) Study in Radiation Oncology
NA · Columbia University · NCT05351424
This study is testing new educational videos and materials to help Spanish-speaking Latinx patients better understand their radiation therapy for breast or prostate cancer and feel more involved in their treatment.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 194 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Columbia University (other) |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 2 sites (Miami Beach, Florida and 1 other locations) |
| Trial ID | NCT05351424 on ClinicalTrials.gov |
What this trial studies
This study aims to create and implement audiovisual educational interventions tailored for Latinx Spanish-speaking patients receiving radiation therapy for breast or prostate cancer. By addressing health literacy and language barriers, the study seeks to improve patient knowledge, adherence to treatment, and participation in clinical trials. The interventions include culturally appropriate materials designed to enhance understanding and decision-making regarding cancer treatment and research participation. The study will also identify factors that influence the quality of radiation therapy delivery and clinical trial enrollment among these patients.
Who should consider this trial
Good fit: Ideal candidates for this study are Spanish-speaking Latinx individuals currently undergoing treatment for non-metastatic breast or prostate cancer.
Not a fit: Patients who are not Spanish-speaking or those with bilateral deafness and/or blindness may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly improve treatment adherence and clinical trial participation among Latinx Spanish-speaking patients with breast or prostate cancer.
How similar studies have performed: While similar educational interventions have shown promise in other settings, this specific approach in radiation oncology is novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Pilot Phase Inclusion Criteria: 1. Spanish speakers of Latinx background as defined by the U.S. Census Bureau as anyone from Mexican, Puerto Rican, Cuban, Dominican, Central or South American ancestry 2. Currently undergoing treatment for breast or prostate cancer, or recently been treated Pilot Phase Exclusion Criteria: 1. Patient with bilateral deafness and/or blindness 2. Patient with psychosis and/or dementia Main Study Inclusion Criteria: 1. Spanish speakers of Latinx background as defined by the U.S. Census Bureau as anyone from Mexican, Puerto Rican, Cuban, Dominican, Central or South American ancestry 2. Patients with non-metastatic prostate or breast cancer 3. Histopathologically proven diagnosis of prostate or breast cancer 4. History and physical examination within 28 days prior to enrollment 5. Karnofsky performance status 70 or greater 6. For women of childbearing potential, pregnancy testing to be performed in accordance to institutional guidelines 7. Plan to receive definitive, curative radiation. Patients planning to receive curative RT after upcoming adjuvant chemotherapy or induction hormonal therapy may enroll at reconsult "follow-up" visit. 8. Consultation visit must be performed with a certified interpreter Main Study Exclusion Criteria: 1. Patient with bilateral deafness and/or blindness 2. Patient with psychosis and/or dementia 3. Clinical or radiological evidence of metastatic disease 4. Prior participation in cancer patient education trial 5. Prior RT 6. RT for sites other than breast or prostate
Where this trial is running
Miami Beach, Florida and 1 other locations
- Mount Sinai Medical Center — Miami Beach, Florida, United States (RECRUITING)
- Columbia University Irving Medical Center — New York, New York, United States (RECRUITING)
Study contacts
- Principal investigator: Lisa Kachnic, MD — Columbia University
- Study coordinator: Christina Chesnakov, MPH
- Email: cc4047@cumc.columbia.edu
- Phone: 646-317-4244
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Breast Cancer Invasive, Prostate Cancer, breast cancer, prostate cancer, audiovisual intervention, Spanish-speaking, focus group, treatment experience